Debbie Zafiropoulos, CEO of the OralED Institute
Debbie Zafiropoulos, Debbie Z as she is respectfully known in the industry, has a go-big or go-home attitude; she is personable, authentic and her passion is contagious. When you meet her, you will want to spend more time in her presence, her energy just radiates! Debbie is the CEO of the OralED Institute, a partner of Delta Force Group Consulting and serves as the Partner in Education for the Wellness Dentistry Network. Debbie is sought out as a collaborator, advisor and KOL for several dynamic corporate companies in the health & wellness industry. As a tireless Pioneer Health Crusader, Educator & Author dedicated to Total Health Initiatives and Making Cancer History. Debbie continues to develop and present cutting edge programs live and often sold out educational programs all over the world. In 2016 Debbie was selected by her peers, her profession and a panel of selected professionals to receive the prestigious Sunstar/UOR Award of Distinction. In 2015 after losing a friend to late stage oral cancer diagnosis after defeating triple negative beast cancer Debbie was determined to stop late stage diagnosis of chronic illness and cancer; this passion drove her to form the NationalCancerNetwork.org a 501(C) (3), whose vision is to raise awareness of prevention, progress, screening and referral resources for a vision of a world free of cancer. Today the NationalCancerNetwork.org is growing into a highly effective and charitable organization helping hundreds with the effects of a cancer diagnosis. This is what led to the search for the best science and products available to support the community. Debbie has introduced StellaLife to patients nationwide searching for effective, not toxic, non-opioid options for pain relief, xerostomia, mucocitis and that enhance healing holistically. Having products like StellaLife's VEGA Oral Care is extremely effective and highly desirable for clinicians to dispense conveniently from the office for the immediate relief and benefit to their patients.